BioLM
1 known investors
BioLM provides AI/ML services for biotech companies, including in-silico generation and screening of protein and enzyme variants, wet-lab synthesis and assay validation, and model fine-tuning for molecule design. It serves clients working on enzymes and antibodies through GPU-backed APIs and a model-agnostic approach to biological data modeling.